Kıyak, Mevlüt2026-08-262026-08-262026Kıyak, M. (2026). Effects of rifaximin in fructose-induced steatohepatitis in rats. Hepatology Forum, 7(3), p. 310. https://doi.org/10.14744/hf.2026.586571307-58882757-7392https://doi.org/10.14744/hf.2026.58657https://hdl.handle.net/20.500.13055/1611To the Editor, I read with interest the recently published article titled “Effects of rifaximin in fructose-induced steatohepatitis in rats.” The article dis cusses how rifaximin may protect against early liver damage caused by fructose. The researchers showed that rifaximin helps reduce cer tain biochemical markers and promote healing in inflamed tissue, providing insight into the interaction between the gut and liver in fatty liver disease, which plays a role in metabolic disorders.eninfo:eu-repo/semantics/openAccessLetter10.14744/hf.2026.5865773310310Q3WOS:001855786400003PMID: 42602231Q3